Cargando…
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort
The majority of prostate cancers harbor recurrent gene fusions between the hormone-regulated TMPRSS2 and members of the ETS family of transcription factors, most commonly ERG. Prostate cancer with ERG rearrangements represent a distinct subclass of tumor based on studies reporting associations with...
Autores principales: | Esgueva, Raquel, Perner, Sven, Lafargue, Christopher, Scheble, Veit, Stephan, Carsten, Lein, Michael, Fritzsche, Florian R., Dietel, Manfred, Kristiansen, Glen, Rubin, Mark A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848699/ https://www.ncbi.nlm.nih.gov/pubmed/20118910 http://dx.doi.org/10.1038/modpathol.2009.193 |
Ejemplares similares
-
5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer
por: Zammarchi, Francesca, et al.
Publicado: (2013) -
ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer
por: ADLER, DAVID, et al.
Publicado: (2012) -
Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer
por: Krumbholz, Manuela, et al.
Publicado: (2019) -
Significance of the TMPRSS2:ERG gene fusion in prostate cancer
por: Wang, Zhu, et al.
Publicado: (2017) -
Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2–ERG-Positive Primary Prostate Cancers
por: von Danwitz, Marthe, et al.
Publicado: (2023)